Correlation Between TNF Pharmaceuticals, and Codexis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TNF Pharmaceuticals, and Codexis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TNF Pharmaceuticals, and Codexis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TNF Pharmaceuticals, and Codexis, you can compare the effects of market volatilities on TNF Pharmaceuticals, and Codexis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TNF Pharmaceuticals, with a short position of Codexis. Check out your portfolio center. Please also check ongoing floating volatility patterns of TNF Pharmaceuticals, and Codexis.

Diversification Opportunities for TNF Pharmaceuticals, and Codexis

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between TNF and Codexis is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding TNF Pharmaceuticals, and Codexis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codexis and TNF Pharmaceuticals, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TNF Pharmaceuticals, are associated (or correlated) with Codexis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codexis has no effect on the direction of TNF Pharmaceuticals, i.e., TNF Pharmaceuticals, and Codexis go up and down completely randomly.

Pair Corralation between TNF Pharmaceuticals, and Codexis

Given the investment horizon of 90 days TNF Pharmaceuticals, is expected to under-perform the Codexis. In addition to that, TNF Pharmaceuticals, is 2.45 times more volatile than Codexis. It trades about -0.34 of its total potential returns per unit of risk. Codexis is currently generating about -0.19 per unit of volatility. If you would invest  514.00  in Codexis on November 7, 2024 and sell it today you would lose (77.00) from holding Codexis or give up 14.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

TNF Pharmaceuticals,  vs.  Codexis

 Performance 
       Timeline  
TNF Pharmaceuticals, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TNF Pharmaceuticals, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Codexis 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Codexis are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Codexis may actually be approaching a critical reversion point that can send shares even higher in March 2025.

TNF Pharmaceuticals, and Codexis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TNF Pharmaceuticals, and Codexis

The main advantage of trading using opposite TNF Pharmaceuticals, and Codexis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TNF Pharmaceuticals, position performs unexpectedly, Codexis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codexis will offset losses from the drop in Codexis' long position.
The idea behind TNF Pharmaceuticals, and Codexis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals